Depression News

The use of GLP-1 receptor agonists corresponded with a lower risk for depression among older adults with type 2 diabetes compared with dipeptidyl peptidase 4 inhibitors, results of a target trial emulation study suggested.

Genetic predisposition to traits such as depressive affect, neuroticism and insomnia appeared significantly associated with greater risk for treatment-resistant depression, according to a study published in JAMA Psychiatry.

Adults with a history of depression gained long-term physical health conditions at a rate 30% faster than those without such a history, an analysis of a UK-based nationwide cohort study in PLoS Medicine showed.

The American Society of Anesthesiologists released new guidance on the safe use of ketamine for nonanesthesia purposes, such as the treatment of mental health disorders, according to an organization press release.

Psilocybin-assisted psychotherapy significantly improved a range of psychiatric symptoms among people with cancer, according to research published in Nature Mental Health.

WEST PALM BEACH, Fla. — A higher comorbidity burden was linked to an increased rate of adverse events as well as early discontinuation among patients with MS who participated in phase 3 clinical trials of disease-modifying therapies, data show.

Patients with chronic prurigo experience high levels of perceived stress, stigmatization and body dysmorphia which are driven by both demographic and disease factors, according to a study.

Patients with dupilumab prescriptions for their atopic dermatitis had lower risks for psychiatric and sleep disorders than those prescribed other treatments, according to a study published in Annals of Allergy, Asthma & Immunology.

Current use of antidepressants corresponded with faster cognitive decline in older adults with dementia, a cohort analysis published in BMC Medicine indicated.